Register entry

Lee Pharma Limited

Registered sites
3
Drug products
14
Live patents
0
Countries
1
Base
India
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites

Facilities

3
SiteLocationOperationsFEI
LEE PHARMA LIMITEDAnakapalliIndiaActive ingredient (API) manufacture3030599910
Lee Pharma LimitedSangareddyIndiaActive ingredient (API) manufacture3009103626
Lee Pharma LimitedVisakhapatnamIndiaAnalytical testing, Labelling, Finished drug manufacture, Packaging3018490749
Catalogue

Marketed products

14

Showing 14 of 14.

BrandGeneric nameFormCategory
-Amlodipine BesylatePOWDERBULK INGREDIENT
-ApixabanPOWDERBULK INGREDIENT
-BrivaracetamPOWDERBULK INGREDIENT
-Cariprazine HClPOWDERBULK INGREDIENT
-EmpagliflozinPOWDERBULK INGREDIENT
-Finerenone APIPOWDERBULK INGREDIENT
-LacosamidePOWDERBULK INGREDIENT
-METAXALONEPOWDERBULK INGREDIENT
-ROSUVASTATIN CALCIUMPOWDERBULK INGREDIENT
-RivaroxabanPOWDERBULK INGREDIENT
-SITAGLIPTIN PHOSPHATEPOWDERBULK INGREDIENT
-TicagrelorPOWDERBULK INGREDIENT
-Tofacitinib Citrate APIPOWDERBULK INGREDIENT
-VARENICLINE TARTRATEPOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.